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ABSTRACT
Immunity is known to be sexually dimorphic. This dimorphism may be attributed to the action
of different hormones. Aluminum is a component of several vaccines and acts as an adjuvant of immunogenicity. The activation of the Nalp3 inflammasome plays a role in aluminum’s adjuvancy. Estrogen
affects immune cells by regulating the expression of genes involved in immune-related mechanisms;
such as the modulation of cytokine secretion. We hypothesized that estrogen modulates the aluminuminduced secretion of IL-1β and IL-18. Using an ex vivo mouse macrophage model this study examined: (i)
the effects of estrogen on Nalp3 inflammasome genes expression and (ii) the estrogen receptor involved
in the modulation of these genes. Our results indicate that estrogen up-regulates Nalp3 gene expression via ERα/β heterodimerization, and caspase-1 activity may be indirectly modulated due to the upregulation of SPI-6 via ERβ.
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1

INTRODUCTION
Since Edward Jenner developed a smallpox vaccine at the turn of the 19th century, vac-

cinations have been an efficient and common means of protecting the population from infectious diseases. Today, a large number of vaccines are administered for many different kinds of
diseases. An adjuvant of a vaccine allows for a more pronounced stimulation of the immune
system, i.e. resulting in higher antibody titers. Aluminum has been administered in vaccines as
an adjuvant since the 1930’s. Rhoads (1930) found an aluminum precipitated antigen to provide
immunity against polio in Rhesus macaques. In 1932, Park and Schroder reported a higher percentage of children obtained immunity when vaccinated with an aluminum precipitated diphtheria toxin. Eventually a large study by Volk and Bunney (1939) included 1,800 children and
found that the best response was induced in patients who took the aluminum precipitated toxoid. The aluminum adjuvant is known to increase the effectiveness of vaccines by increasing
antibody titers (Volk and Bunney 1941; Gupta 1998). The initial findings suggested that absorption of the toxoid/antigen onto the aluminum resulted in the precipitation of the toxoid/antigen from it, resulting in a steady release of antigen (Carlinfanti 1949; Gupta 1998). In
theory, this steady release would maintain stimulation of the immune response longer and is a
result of the adjuvant’s action.
It has been recently established that a protein complex known as the ‘Nalp3 inflammasome,’ found within, but not limited to, monocytes, macrophages, and dendritic cells (Eisenbarth, Colegio et al. 2008), allows for aluminum's adjuvancy. The complex is composed of several proteins: Nalp3, ASC, pro-Caspase-1, and possibly CARDINAL. The protein nucleotide-
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binding site (a.k.a. nucleotide-binding oligomerization domain) and leucine-rich repeats with Nterminal pyrin domain containing 3 (Nalp3), seems to be the first cellular proteins to be involved. This protein is constitutively expressed, but without appropriate signals remains in an
inactive conformation with interactions with HSP90 and SGT1. (Mayor, Martinon et al. 2007).
Upon stimulation with danger associated molecular patterns, such as ATP or pathogen associated molecular pattern, Nalp3 is presumed to detach from HSP90 and SGT1 and exposes the
pyrin domain (Duncan, Bergstralh et al. 2007; Mayor, Martinon et al. 2007). The activation of
Nalp3 is followed by the binding of apoptosis-associated speck-like protein containing a caspase
recruitment domain (ASC) to Nalp3’s pyrin domain (Mariathasan, Newton et al. 2004; Franchi
and Gabriel 2008). This model suggests that ASC (as well as CARDINAL, in humans), once bound
to Nalp3, allows for the binding of pro-caspase-1, resulting in caspase-1 activation (Agostini,
Martinon et al. 2004; Mariathasan, Newton et al. 2004; Petrilli, Dostert et al. 2007; Church,
Cook et al. 2008). The activated caspase-1 can now cleave pro-cytokines IL-1β and IL-18, turning them into active cytokines (Thornberry 1992; Gu, Kuida et al. 1997; Eisenbarth, Colegio et
al. 2008; Franchi and Gabriel 2008). Aluminum salts activate the Nalp3 protein, either directly
or indirectly and aluminum’s adjuvancy manifests in the secretion of the IL-1β and IL-18 cytokines (Li, Nookala et al. 2007; Eisenbarth, Colegio et al. 2008; Gregorio, Tritto et al. 2008; Li,
Willingham et al. 2008).
The cytokines IL-1β and IL-18 are included in the IL-1 gene family, but produce different
effects on the cells they target. IL-1β is an endogenous pyrogen, or inflammatory inducer, and
acts on many different types of tissues; it induces fever, dilation of vascular endothelium, and
increasing expression of cell adhesion molecules (Parham 2009). IL-1β can also activate B-cells
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and T-cells. IL-18 contributes to inflammation and can be produced by different cell types, including macrophages (Stoll, Jonuleit et al. 1998; Murakami, Otsuki et al. 2005; Dinarello 2006),
and, together with IL-2 or IL-12, co-stimulates the production of interferon-γ and other cytokines from T-cells and macrophages, among others (Dinarello 1996, 2006, 2009). This costimulation aids in the development of type 1 T helper cells, via interferon-γ (Dao, Ohashi et al.
1996; Stoll, Jonuleit et al. 1998), which function to activate macrophages (Parham 2009).
Studies have shown that after having been stimulated with appropriate factors, mice deficient in Nalp3, ASC, or Caspase-1 are unable to secrete cytokines (Mariathasan, Newton et al.
2004; Franchi and Gabriel 2008; Kool, Petrilli et al. 2008; Li, Willingham et al. 2008). Aluminum
does not stimulate the production of cytokines, but rather only activates the Nalp3 protein; the
synthesis of cytokines involves a separate pathway, including Toll-like-receptor ligands such as
lipopolysaccharides (LPS) (Li, Nookala et al. 2007; Li, Willingham et al. 2008). In addition to the
Nalp3 protein’s importance in the secretion of these cytokines, higher antibody titers have also
been attributed to Nalp3 gene expression; titers against a specific antigen are decreased in
Nalp3 knock-out mice (Eisenbarth, Colegio et al. 2008; Li, Willingham et al. 2008).
Varying effectiveness of vaccines between the sexes has been reported (Giron-Gonzalez,
Moral et al. 2000; Card, Carey et al. 2006; Cook 2008). All the factors for this sexual dimorphism are not known, but it has been shown that estrogen plays a role in immunity and/or on
immune cells (Hu, Mitcho et al. 1988; Deshpande, Khalili et al. 1997; Kramer and Wray 2002;
Masseoud 2008; Nguyen, Masseoud et al. 2011). Estrogen has been found to affect IL-1 production of monocytes/macrophages, seemingly increasing IL-1 production (Yoshida, Nakamura et
al. 1996), with negative feedback at higher concentrations (Hu, Mitcho et al. 1988; Polan, Da-

4

niele et al. 1988; Polan, Loukides et al. 1989). However, a more recent study found that human
peripheral blood monocytes increase IL-1β secretion at high levels of estradiol (100 nM) (Pioli,
Weaver et al. 2006). In correlation with this, 17β-estradiol (E2) up-regulates IL-1β mRNA expression (Harris, Feldberg et al. 2000; Pioli, Weaver et al. 2006). Estrogen-estrogen receptor
complex is known to enhance the IL1-β promoter (Ruh, Bi et al. 1998). Also, an estrogen responsive B box protein has been identified to interact with proIL-1β, enhancing secretion (Munding, Keller et al. 2006). Further, the IL-1β transcription factor, NF-κB, was shown to interact
with estrogen receptor α (Ghisletti, Meda et al. 2005; Gionet, Jansson et al. 2009), but the effects are not clear.
However, a contradictory report suggests a down regulation of IL-1 secretion monocytes/macrophages in response to E2 (Deshpande, Khalili et al. 1997; Morishita, Miyagi, and
Iwamoto 1999). Another study showed that sera from male mice express higher responses to
LPS stimulation with respect to cytokine secretion (Marriott, Bost et al. 2006). This same study
showed that male macrophages secrete more IL-1β in vitro, than females. Further, a trend of
lower IL-1β levels was observed from cells of postmenopausal women undergoing estrogen replacement therapy than those not undergoing the therapy (Rogers and Eastell 1998). Similarly,
postmenopausal women were found to have increased IL-18 levels than fertile women (Cioffi,
Esposito et al. 2002). In addition to contrary data, human monocyte-derived macrophages
were shown not to alter IL-1β gene expression levels in the presence of E2 at low or high concentrations (Corcoran, Meydani et al. 2010). Also, a study by Lewis et al. (2008) shows no effect
on IL-1β secretion in microglia when treated with 17β-estradiol, but a reduction when treated
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with DPN, an ERβ agonist. Estrogen has also been shown to impact IL-18 mRNA production,
which was inhibited in the mouse uteri (Murakami, Otsuki et al. 2005).
In addition to the direct modulation of IL-1β and IL-18 gene expression, estrogen receptors can up-regulate the expression of a caspase-1 inhibitor, serine protease inhibitor 6 (SPI-6),
which also inhibits granzyme B, a cytotoxic enzyme secreted by cytotoxic T-cells and natural
killer cells. SPI-6 gene expression is induced in response to both LPS and IL-1β in some immunoprivileged cells, suggesting a negative feedback mechanism for controlling inflammation
and/or protection from granzyme B degradation (Kannan-Thulasiraman and Shapiro 2002; Bots,
de Bruin et al. 2007; Andrew, Simkins et al. 2008). The SPI-6 gene, Serpinb9, contains an estrogen responsive unit downstream of the transcription site and is responsible for estrogen induced expression (Krieg, Krieg, and Shapiro 2001; Krieg, Krieg et al. 2004). Regardless of the
influence that estrogen may have on the expression of SPI-6, Stout-Delgado et al. (2007) found
no difference in expression between genders in hepatocytes from mice challenged with a viral
infection. The expression of SPI-6 is well established in the dendritic cell model, an antigen presenting cell of the myeloid lineage (Andrew, Simkins et al. 2008); immunohistological data of
multiple tissues showed negative staining for SPI-6 in macrophages (Bladergroen, Strik et al.
2001). However, preliminary data from our lab suggests SPI-6 expression in the peritoneal macrophage cell line PMJ2, but estrogenic modulation was not present (unpublished). The expression in macrophages and the potential estrogenic modulation of this gene may imply a mechanism for estrogenic control of the Nalp3 inflammasome activity, namely the ability of caspase-1
to cleave pro-cytokines IL-1β and IL-18.
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The clinical implications of estrogenic modulation of the inflammasome genes can be
applied to macrophagic myofasciitis and several chronic inflammatory diseases, collectively
known as cryopyrin-associated periodic syndrome (CAPS). CAPS is attributed to mutations
within the Nalp3 gene (Hoffman, Mueller et al. 2001; Verma, Eriksson et al. 2010; Hoffman and
Brydges 2011). Agostini et al. (2004) showed that monocytes from individuals with MuckleWells syndrome, a type of CAPS, constitutively secrete IL-1β, and these levels were only slightly
lower than stimulated macrophages from normal donors. Murine bone marrow derived macrophages containing a Nalp3 mutation that is common among sick individuals produce constitutive IL-1β and the addition of pathogen associated molecular patterns induced further secretion without the aid of a Nalp3 activator, such as ATP (Meng, Zhang et al. 2009). Therapy for
CAPS often addresses the suppression of IL-1β, via antagonists, namely, Anakinra. Macrophage
myofasciitis is a newly described chronic inflammatory disease which is attributed to the inability of the body to remove the aluminum that is injected with a vaccine and thus causing chronic
stimulation of macrophages at the site; the presence of aluminum within macrophages at the
injection site of vaccines have repeatedly been reported (Lacson, D’Cruz et al. 2002; Lach and
Cupler 2008). If estrogen has the ability to regulate the inflammatory response, via Nalp3 inflammasomal modulation, then an increase in systemic estrogen has the potential to influence
the degree and duration of chronic inflammation in patients with macrophage myofasciitis or
CAPS.
Preliminary data from our lab show that in the presence of 17β-estradiol Nalp3 gene expression is up-regulated when the peritoneal macrophage PMJ2 is stimulated with ATP; however, this modulation is not present when stimulated with aluminum hydroxide (unpublished). If
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estrogen modulates the expression of Nalp3 inflammasome genes the diseases associated with
it can be understood on a gender basis. Also, controlling hormonal levels in these patients may
be viewed as a possible therapeutic approach.
There are many factors involved in the processing of both steroids and cytokines, making it difficult to obtain a clear understanding of estrogen’s impact on IL-1β. Currently, there
are no studies that have observed estrogen's effects on aluminum adjuvancy. This study seeks
to understand estrogen effects on Nalp3 associated gene expression. Determining the impact
that estrogen may have on aluminum induced cytokine secretion and on Nalp3 inflammasome
gene expression may help understand how estrogens impact aluminum adjuvancy. It is hypothesized that 17β-estradiol will: (i) decrease aluminum induced IL-1β secretion from murine
bone marrow-derived macrophage, and (ii) up-regulate SPI-6 gene expression via estrogen receptor β. In support of this hypothesis, cells treated with E2 and diarylpropionitrile (DPN), an
ERβ agonist, are expected to show lower levels of IL-1β in the supernatant, and this will correlate with an increase in gene expression of SPI-6.
1.1

Purpose of the Study
No study has addressed the influence of estradiol on aluminum adjuvancy. This study

investigates how estradiol modulates the genes of the Nalp3 inflammasome, which is a key factor in aluminum adjuvancy. The genes of direct interest to the inflammasome are: Nalp3, ASC,
and Caspase-1. Other genes that influence the function or outcome of the inflammasome were
also investigated: namely, IL-1β and SPI-9. This study also attempts to determine the estrogen
receptor responsible for the modulation of Nalp3 inflammasome genes by using specified estrogen receptor agonists.
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2
2.1

EXPERIMENTS
Animals
Female BALB/c mice (Charles River Laboratories, Inc., Wilmington, MA) were housed to-

gether in an individually ventilated cage with a 12hr day and night cycle (lights from 7am –
7pm). Cages and water were replaced once a week. Chow was isoflavone and soy-free (Stewart’s Feed, #5K96). All animal procedures were conducted in agreement with the institutions
policies and by the guidelines of the IACUC approved protocol.
2.2

Ovariectomy
At the age of 10.5 weeks, mice were anesthetized with 5% isoflurane gas in 100% medi-

cal grade oxygen. Mice were administered subcutaneously buprenorphine (0.1 mg/kg). While
on a heating pad the mice’s ovaries were removed by dorsal entry. The incisions were stapled
and allowed to fall off naturally.
2.3

Isolation of Bone Marrow Derived Macrophages (BMDM)
At 6 months of age, mice were anesthetized with 5% isoflurane gas in 100% medical

grade oxygen and euthanized by axillary cut-down. Femur and tibia bones were removed and
tissue was removed. The bone epiphyses were removed in a biosafety cabinet and bone marrow was flushed out with RPMI1640 (Gibco) until the bone was white. The marrow plugs were
mechanically disrupted with a 19-G needle and filtered through a 70 μm cell strainer. Each
mouse’s bone marrow was cultured in two non-culture treated petri dishes with 20 ml of complete media (PRMI1640 supplemented with 10% FBS, 5 mM glutamine, 1 mM HEPES, and 1%
Pen-Strep (Gibco), plus 10 ng/ml M-CSF (Leinco). On day 3, 5 ml of media was removed and an
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additional 10 ml of complete media was added; the complete media was replaced on day 6. On
day 7 cells were identified by flow cytometry with staining for F4/80 (Invitrogen) and CD11(b)
(BD Pharmingen).
2.4

Cell Culture Stimulation
On day 8 of culture, cells were counted and plated in 12-well plates at 5x105 cells per

well in 2 ml. After 24 hrs the media was replaced with 1 ml of hormone-free media (complete
media without phenol red and containing charcoal-stripped FBS) supplemented with either
ethanol dissolved 17β-estradiol (E2) at 1 or 10 nM, propypyrazoletriphenol (PPT) at 5 nM, or
diarylpropionitril (DPN) at 10 nM, or vehicle (ethanol at 0.001%) for 12 hrs. PPT served as an
ERα agonist (Stauffer, Coletta et al. 2000), whereas DPN served as an ERβ agonist (Meyers, Sun
et al. 2001). Cells were then primed with lipopolysaccharide (LPS) at 100 ng/ml for 1 hr with
their respective hormone. This was replaced with media containing their respective hormone,
LPS, and aluminum hydroxide (Al) at 125 μg/ml for 6 hrs. Positive controls were
primed/stimulated with LPS without hormones or aluminum for 7 hrs and ATP at 5 mM for the
last 20 min. All reagents were obtained from Sigma-Aldrich.
2.5

Supernatant and RNA collection
Supernatants were removed and centrifuged at 10,000 x g for 10 min at 4°C, then frozen

at -80°C. Aluminum containing groups were washed 3X with PBS before RNA extraction. RNA
was obtained using the RNeasy kit (Qiagen) according to manufactures protocol, and stored at
-20°C.
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2.6

ELISA
ELISA was conducted using a mouse IL-1β ELISA Set (BD OptEIA). Coating buffer was a

1 M phosphoric acid solution. Assay diluent was a 5% FBS in PBS solution. The stop buffer was a
1 M phosphoric acid solution. Samples were diluted 1/50. None stimulated groups (no aluminum or LPS) were conducted in either duplicates or triplicates. Aluminum containing samples
were assayed in triplicates. Multiple assays were performed.
2.7

Real-Time PCR
Total RNA (2 μl) was reverse transcribed with AMV reverse-transcriptase (Roche) in the

presence of RNase inhibitor (Roche) using random primers (Roche). Diluted (1/20) cDNA underwent real-time PCR using Taqman® Gene Expression Assay (Applied Biosystems) in a 7500
Fast-Realtime machine (Applied Biosystems). Relative quantification was derived by ΔΔCt, with
β-actin as the endogenous control.
2.8

Flow Cytometry
Cells (3x105) were stained for either anti-mouse F4/80 PE conjugate (Invitrogen) or anti-

mouse CD11(b) FITC conjugate (BD Pharmingen). F4/80-PE antibody was compared to an isotype control (Biolegend), whereas the CD11(b)-FITC antibody was compared to an unstained
cell sample.
2.9

Statistical Analysis
One-way ANOVA analysis was conducted with post-analysis using Tukey’s multiple com-

parison test to determine significance. A p-value of <0.01 was considered statistically significant.
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3
3.1

RESULTS
BMDM were Positive for F4/80 and CD11(b)
After 7 days of culture, bone marrow derived macrophages (BMDM) were stained for

F4/80 expression to determine the purity of the derived macrophages. Over 98% of the cells
expressed F4/80, deeming them murine macrophages (Figure 1.1). These cells were also assayed for a common monocyte/macrophage receptor, CD11(b), which was expressed at >90%
of the cells (Figure 1.2).

Figure 1.1 BMDM were F4/80 Positive. Bone Marrow Derived Macrophages (BMDM) (3x105 cells) were stained with F4/80 antibody
or an isotype control (PE conjugates) and analyzed by flow cytometry. Percentage is of 20,000 recorded events.

Figure 1.2 BMDM were CD11(b) Positive. Bone Marrow Derived
Macrophages (BMDM) (3x105 cells) were stained with CD11(b) antibody (FITC conjugate) or unstained and analyzed by flow cytometry.
Percentage is of 20,000 recorded events.
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3.2

17β-estradiol Increased Nalp3 Expression
To determine how Nalp3 gene expression responds to particular estrogen receptor

agonists, BMDM were stimulated with aluminum hydroxide (Al) and LPS and cDNA was assayed
by real-time PCR (Figure 2.1-2). Estradiol (E2) up-regulated Nalp3 gene expression in a dose
dependant manner; in unstimulated cells the gene expression increased 2 and 2.5-fold with E2
at 1 and 10 nM, respectively. This similar pattern was observed in the stimulated groups, however it was not statistically significant (p>0.05). The Nalp3 gene expression in the no hormone
group increased ~56-fold after stimulation; whereas in the presence of 1 nM E2 the increase
was ~62-fold, and at 10 nM E2 it was some ~68-fold. This increase – after treatment with 10
nM E2 – in stimulated macrophages was 20% more than the no hormone group. After stimulation and in the presence of diarylpropionitrile (DPN), an estrogen receptor (ER) beta agonist,
Nalp3 gene expression increased to a similar degree as macrophages stimulated in the presence
of E2 at 1 nM; propylpyrazoletriphenol (PPT), the ERα agonist, did not express this similar effect. Unstimulated macrophages treated with either PPT or DPN did not up-regulate Nalp3 expression.
The increase in endogenous expression of Nalp3 expression in response to E2 and not
either of the ER agonists suggests that this modulation is attributed to the heterodimerization
of ERα and β, both of which bind E2. The up-regulation in the presence of E2 may deem these
cells more readily responsive to Nalp3 activating molecules.
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Figure 2.1 17β-estradiol Increased Endogenous Nalp3 Gene Expression. BMDM were cultured in the
presence or absence of estrogen receptor agonists for 17 hrs. “No Hormones” group contains no estrogen receptor agonists, and is the reference point of expression. Hormone containing groups are: E2,
estradiol; PPT, ERα agonist; DPN, ERβ agoinist. Error bars represent the standard deviation of triplicate
samples assayed in triplicates. ** (p<0.001) derived using Tukey’s multiple comparison test.
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Figure 2.2 17β-estradiol Increased Nalp3 Gene Expression in Stimulated Macrophages. BMDM were cultured in the presence or absence of estrogen receptor agonists for 12 hrs prior to stimulation with LPS
(100 ng/ml) for 1 hr and another 6 hrs with aluminum hydroxide (125 μg/ml). Quantification is normalized to a non-stimulated and no hormone containing group (not shown). Hormone containing groups
are: E2, estradiol; PPT, ERα agonist; DPN, ERβ agoinist. Error bars represent the standard deviation of
triplicate samples assayed in triplicates.
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3.3

Stimulation of BMDM Decreased the Gene Expression of ASC
For Nalp3 to active caspase-1, via proteolytic cleavage, the protein ASC is required to

link the two proteins. Figure 3.1 shows how estrogen receptor agonists affect ASC gene expression before and after stimulation of BMDM with Al and LPS. Estradiol did not affect the endogenous expression of ASC. The estrogen receptor α and β agonists, PPT and DPN, respectively,
down-regulated the expression of this gene in unstimulated cells; however, the reduction was
minor. After stimulation, the macrophages expressed about half as much ASC. This decrease
was not altered in the presence of any of the hormones tested.

Relative Quantification (ddCT)
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DPN (10nM)

Figure 3.1 Stimulation of BMDM with Aluminum and LPS Down-regulated ASC Gene Expression. BMDM
were cultured in the presence or absence of estrogen receptor agonists for 12 hrs prior to stimulation
with LPS (100 ng/ml) for 1 hr and another 6 hrs with aluminum hydroxide. Quantification is normalized
to the unstimulated and no hormone containing group. Hormone containing groups are: E2, estradiol;
PPT, ERα agonist; DPN, ERβ agonist. Error bars represent the standard deviation of triplicate samples
assayed in triplicates.
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3.4

Estrogen Receptor Agonists Modulated Caspase-1
The expression of caspase-1 is vital to the adjuvancy effects of aluminum on macro-

phages, so it was of interests to determine whether estrogen modulates the expression of this
gene (Figure 4.1). DPN, an ERβ agonist, up-regulated caspase-1 in stimulated macrophages;
DPN resulted in over a 3-fold increase, whereas no hormones yielded a 2.5-fold increase. The
increase was modest when cells were treated with estradiol, for both 1 nM and 10 nM concentrations. PPT, an ERα agonist, increased the gene expression 3-fold, slightly higher than estradiol. This would suggest that the gene may be modulated in stimulated macrophages by ERα,
and to a greater extent, ERβ. Endogenous levels of the gene were not altered in the presence
of any of the tested hormones.

Relative Quantification (ddCT)
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Figure 4.1 Estrogen Receptor Beta Increased Caspase-1 Gene Expression. BMDM were cultured in the
presence or absence of estrogen receptor agonists for 12 hrs prior to stimulation with LPS (100 ng/ml)
for 1 hr and another 6 hrs with aluminum hydroxide. Quantification is normalized to a non-stimulated
and no hormone containing group. Hormone containing groups are: E2, estradiol; PPT, ERα agonist;
DPN, ERβ agoinist. Error bars represent the standard deviation of triplicate samples assayed in duplicates (Unstimulated) or triplicates (Stimulated). *(p<0.01), ** (p>0.001), derived using Tukey’s multiple
comparison test as compared with stimulated No Hormone group.
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3.5

Serpinb9 was Up-regulated in Stimulated Macrophages via ERβ
To determine a possible mechanism by which estrogen may inhibit IL-1β secretion, the

expression of the gene Serpinb9, which codes for a natural inhibitor of caspase-1, was determined (Figure 5.1). In the BMDM cell model, activation with LPS and aluminum increased the
expression of Serpinb9; this suggests that Serpinb9 is an inflammatory response gene. After
activation, macrophages in the presence of DPN, an ERβ agonist, increased Serpinb9 expression
5-fold, as compared to the unstimulated and no hormone containing group; whereas a stimulated cells without hormones only increased gene expression by roughly 2-fold. This deems
Serpinb9 an ERβ responsive gene, but up-regulation only occurs after cell stimulation/activation; DPN, and PPT, down-regulated the endogenous gene expression levels of Serpinb9 to half the level of both no hormone and estradiol containing groups.

Relative Quantification (ddCT)
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**
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Unstimulated
Stimulated
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No Hormones

E2 (1nM)

E2 (10nM)

PPT (5nM)

DPN (10nM)

Figure 5.1 Estrogen Receptor Beta Increased Serbinb9 Expression in Stimulated Macrophages. BMDM
were cultured in the presence or absence of estrogen receptor agonists for 12 hrs prior to stimulation
with LPS (100 ng/ml) for 1 hr and another 6 hrs with aluminum hydroxide. Quantification is normalized
to a non-stimulated and no hormone containing group. Hormone containing groups are: E2, estradiol;
PPT, ERα agonist; DPN, ERβ agoinist. Error bars represent the standard deviation of triplicate samples
assayed in triplicates. ** (p>0.001), derived using Tukey’s multiple comparison test as compared with
stimulated No Hormone group.
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3.6

BMDM Constitutively Expressed IL-1β mRNA, but at Much Lower Levels then when Stimulated
IL-1β secretion is central to the Nalp3 inflammasome’s function, so determining how es-

tradiol might influence its gene expression can help in determining possible modulation of aluminum adjuvancy by estradiol. BMDM constitutively express IL-1β mRNA, and PPT and DPN
down-regulated these levels (Figure 6.1). However, these levels are minute when compared to
stimulated cells. After stimulated with LPS and Al, IL-1β gene expression in BMDM increased
about 650-fold. Unlike the endogenous levels, in this model none of the estrogen receptor
agonists influenced the levels of IL-1β gene expression in activated cells (Figure 6.1).

*

*

6.1 BMDM Increased Production of IL-1β mRNA after Stimulated. BMDM were cultured in the presence
or absence of estrogen receptor agonists for 12 hrs prior to stimulation with LPS (100 ng/ml) for 1 hr and
another 6 hrs with aluminum hydroxide. Quantification is normalized to a non-stimulated and no hormone containing group. Hormone containing groups are: E2, estradiol; PPT, ERα agonist; DPN, ERβ
agoinist. Error bars represent the standard deviation of triplicate samples assayed in triplicates.
*(p<0.05), derived using Tukey’s multiple comparison test as compared with non-stimulated No Hormone group.
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3.7

17β-estradiol did not Modulate IL-1β Secretion in BMDM Stimulated with Aluminum
and LPS
To determine if estrogen receptor agonists modulate the amount of IL-1β secreted from

BMDM in response to Al and LPS, ELISA assays were conducted on the supernatants from the
cell cultures stimulated with these reagents. No significant modulation was observed in any of
the stimulation groups (Figure 2.1). No secretion was detected in groups that were not stimulated with Al and LPS (data not shown).

35
30

IL-1β (ng/ml)

25
20
15
10
5
0
No Hormone

E2 (1nM)

E2 (10nM)

PPT (5nM)

DPN (10nM)

Positive Control

Figure 7.1 Estrogen Receptor Agonists Did Not Modulate IL-1β Secretion in BMDM Stimulated with Aluminum and LPS. All groups were cultured in hexlicates, except E2 (10 nM) which was conducted in triplicates. Cells were stimulated with LPS (100ng/ml) for 1 hr, followed by aluminum hydroxide (125µg/ml)
for 6 hr, except the Positive Control, which was stimulated with LPS for 7 hr and ATP (5 mM) for the last
20 min. Hormone containing groups are: E2, estradiol; PPT, ERα agonist; DPN, ERβ agoinist. Error bars
represent standard error of the mean from six different samples, except E2 (10 nM) which is of three
culture samples, assayed three different times in triplicates each time.
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4

DISCUSSION
Estrogen is known to modulate several parameters of the immune system (reviewed in

Bouman, Heineman, and Faas 2005). Classical estrogen receptors, ERα and ERβ, are well established transcription factors that function by dimerization in either a homo- or a hetero- fashion
(Kumar and Chambon 1988; Ogawa, Inoue et al. 1998). Here we investigated how 17β-estradiol
(E2) might modulate the gene expression of the Nalp3 inflammasome genes - Nalp3, ASC, and
Caspase-1 – with and without lipopolysaccharide (LPS) and aluminum hydroxide (Al) activation
of macrophages. In addition to E2, two estrogen receptor (ER) agonists were used: propylpyrazoletriphenol (PPT), an ERα agonist, and diarylpropionitrile (DPN), an ERβ agonist. Bone marrow derived macrophages (BMDM), which express the characteristic macrophage markers
F4/80 and CD11(b) (Fig. 1.1 & 1.2, respectively), are a common in vitro model in the study of the
Nalp3 inflammasome. We also investigated the influence E2 and the ER agonists might have on
IL-1β gene expression and secretion in these cells.
If E2 has a role in modulating Nalp3 expression, then the implications may be extensive.
Several chronic inflammatory diseases, collectively called CAPS, result from a constitutively active Nalp3 protein; expression of Nalp3 leads to uncontrolled secretion of IL-1β, an endogenous
pyrogenic cytokine. Estrogen has been implicated in rheumatoid arthritis (reviewed in Islander,
Jochems et al. 2011), and Nalp3 induced IL-1β has been implicated in gout (Joosten, Netea et al.
2010). To date, no reported study has determined whether E2 regulates the Nalp3 gene. Our
results show that E2 up-regulates the endogenous levels of Nalp3 mRNA, and that this upregulation is likely a result of heterodimerization of ERα and β; PPT and DPN, ERα and ERβ
agonists, respectively, did not show any up-regulation in this gene. Further, the subsequent
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increase in Nalp3 expression after increasing the E2 concentration to 10 nM suggests that this
up-regulation is dose-dependent. This up-regulation by E2 was not apparent in the stimulated
macrophages. Instead, stimulated cultures that were treated with E2 at 10 nM show a slight
increase in Nalp3 gene expression, but the significance was not evident. The clear upregulation of the Nalp3 gene in macrophages that have not been stimulated with LPS and Al
may enable the cells to respond more strongly or quickly to a Nalp3 activator and hence would
express the phenotypic manifestation of caspase-1 activation more readily. This would be a
kinetically based response and whose effects have peaked within the six hours of stimulation
that the current model used, and whose residual effects are seen by the slight variation in the
stimulated cells. To verify this hypothesis, a kinetic study with multiply time points would have
to be conducted. Even though E2 did not significantly influence Nalp3 gene expression in stimulated cells, the statistically significant endogenous up-regulation of Nalp3 by E2 may be implicated in the cryopyrin-associated periodic syndrome, wherein increased estrogen levels may
lead to an immune flare-up.
ASC is an adaptor protein, linking caspase-1 to Nalp3, resulting in caspase-1 activation.
The ASC gene was shown to decrease 2-fold in response to the LPS and Al stimuli. Indeed,
Taxman et al. (2006) observed a sharp decrease in ASC mRNA expression in the human monocytic cell line THP-1, after 6 hrs of infection with Porphyromonas gingivalis, a gram-negative
bacterium. The down-regulation of ASC in response to 6 hrs of stimulation may suggest a negative feedback to the inflammatory response, preventing the cell from inducing inflammation for
too long of a period. The hormonal effects on the expression of ASC were not seen in either the
unstimulated or stimulated cultures, suggesting that this gene is not modulated by estrogen.
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The presence of caspase-1 is vital for an effective Nalp3 response. Caspase-1 is constitutively expressed and is up-regulated in response to LPS and Al (Figure 4.1). The endogenous
level of caspase-1 gene expression is not affected by estrogen receptor agonists in cells that are
not stimulated. However, DPN was found to significantly increase the levels of caspase-1 mRNA
in stimulated macrophages. This increase suggests that ERβ is an activator of this gene; interestingly though, neither of the E2 concentrations led to this increase. An increase in caspase-1
gene expression was observed in response to E2 in pigs’ endometrium (Ashworth, Ross et al.
2010); however, these animals were not challenged with any type of PAMP and thus do not
correlate with our data. Our data suggest that ERβ up-regulates caspase-1 gene expression only in the presence of other stimuli, likely LPS, which is known to recruit a multitude of transcription factors resulting in an interaction. This suggests that ERβ requires the presence of other
transcription factors to function as an activator of transcription. Indeed, Quaedackers et al.
(2007) showed ERα to directly interact NF-κB proteins p50 and p65, which are up-regulated in
LPS stimulated cells (Zandi, Rothwarf et al. 1997). Also, E2 was shown to increase NF-κB activity
in splenic macrophages (Suzuki, Yu et al. 2008). Thus, it is possible to imagine how NF-kB transcription factors may interact with estrogen receptors. Because 17β-estradiol binds both ERα
and β, the lack of caspase-1 gene expression increase after stimulation of macrophages in the
presence of E2 may be due to antagonism by ERα, whereby ERα acts as a decoy for E2, preventing enough ERβ ligation for the activation of caspase-1.
Several studies have suggested that the protein SPI-6, gene name Serpinb9, can inhibit
caspase-1 activity (Annand, Dahlen et al. 1999; Kannan-Thulasiraman and Shapiro 2002). Furthermore, Serpinb9 has been shown to be up-regulated in response to estrogens (Krieg, Krieg,
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and Shapiro 2001; Krieg, Krieg et al. 2004). As mentioned above, caspase-1 is crucial to the secretion of IL-1β and its inhibition would result in lower secretion levels of IL-1β; thus, if estrogen
modulates IL-1β secretion it would be of interest to determine if Serpinb9 up-regulation would
correlate. Our data show that endogenous levels of Serpinb9 were not affected by either of the
E2 concentrations, but that the ERα and β agoinsts, PPT and DPN, respectively, decreased the
expression levels roughly 2-fold (Figure 5.1); however this was not statistically significant. LPS is
known to increase the expression of Serpinb9 (Kannan-Thulasiraman and Shapiro 2002; Andrew, Simkins et al. 2008), which would explain the up-regulation of the gene among all the stimulated groups. More interestingly though, was the large and significant up-regulation of Serpinb9 in response to DPN after stimulating the macrophages. This is contrary to Dr. David J.
Shaprio’s team at the University of Illinois, which consistently attributes ERα to the upregulation of Serpinb9 (Krieg, Krieg et al. 2004; Jiang, Ellison et al. 2007). Our data does suggest
an increase similar to that of E2, at 1 nM, in response to the ERα agonist. Taking this into account, it is worth noting the lack in increase in E2 at 10 nM, which suggest an E2 threshold in
acting as an activator of transcription. However, these data points contain lots of variation and
are not statistically significant.
Several studies have attributed ERβ to decreased immune responses in microglia (Baker,
Brautigam and Watters 2004; Lewis, Johnson et al. 2008), the macrophages of the central nervous system. The 5-fold increase in Serpinb9 in response to DPN, as compared to the roughly 2fold increase in other stimulated hormonal groups, would suggest that ERβ has a potential to
inhibit IL-1β secretion via SPI-6. However, our data did not support such a hypothesis; the IL-1β
secretion levels remained similar. One possibility for a lack of reduction in IL-1β secretion can
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be due to Serpinb9 not being translated and thus no phenotypic modulation is seen. Indeed,
macrophages where negative for PI-9, the human homolog, in lymphoid tissue samples; however, these samples were derived from normal human tissues (Bladergroen, Strik et al. 2001).
The secretion of IL-1β from macrophages stimulated with LPS and Al for six hours did
not differ in the presence of any of the ER agonists tested (Figure 7.1). These data correlate
well with the lack of modulation of IL-1β gene expression (Figure 6.2), which is in agreement
with human monocyte-derived macrophages (Corcoran, Meydani et al. 2010). The inability of
the DPN up-regulated SPI-6, whose increased protein levels are assumed due to the increased
mRNA levels, to reduce the amount of IL-1β secretion may be offset by a corresponding upregulation of caspase-1. Another explanation is that Serpinb9 might not have been upregulated before the six hour mark. Without kinetic gene expression data we cannot determine
if the observed up-regulation of Serpinb9 by DPN only just occurred at the six hour mark, and
that the manifestation of caspase-1 inhibition – reduced IL-1β secretion – can only be observed
after this time point. Lewis et al. (2008) showed that DPN decreased IL-1β secretion from LPS
stimulated microglia, after 24 hours of stimulation. Our study chose six hours because LPS stimulated IL-1 mRNA peaks at this time point (Dinarello, Muegge, and Durum 2000).
Other factors that may have led to the lack of observable differences in IL-1β secretion
is the presence of M-CSF, a growth factor essential to BMDM, or the presence of LPS concentrations that are too high. Cells respond upon reaching a threshold level of stimulation; further,
the response is not expressed until intracellular biochemical responses reach a particular threshold. This phenomenon explains the varying cellular responses to different concentrations of
stimuli. M-CSF is known to influence IL-1β secretion and activation of macrophages in general
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(Evans, Kamdar et al. 1995; Popova, Kzhyshkowska et al. 2011). Its presence was perhaps not
essential, but is common in the macrophage milieu. The M-CSF concentrations used in this
study (10 ng/ml) could have masked the effects that E2 might have had on the secretion of IL1β by exacerbating the macrophage’s response to the LPS and Al stimuli. The LPS concentration, 100 ng/ml, may also have been too high. A response curve was not conducted on these
cells, so similarly to the M-CSF, LPS might have masked the potential effects of estrogen on IL1β secretion.

5

CONCLUSIONS
Estrogen receptor agonists estradiol, PPT, and DPN modulate gene expression of partic-

ular Nalp3 inflammasome genes. Nalp3 gene expression was increased by estradiol at 1 nM
and to a higher degree with 10 nM. Nalp3 modulation by estradiol may be attributed to heterodimerization of estrogen receptor (ER) α and β; PPT and DPN, ERα and ERβ agonist, respectively, did not show any increase in gene expression. Caspase-1 was up-regulated by all three
agonists; caspase-1 gene expression is modulated by both ERα and ERβ, but ERβ seems to have
a higher degree of influence. IL-1β gene expression was not modulated by estradiol, PPT, or
DPN in this model. SPI-6 gene expression in macrophages was up-regulated in response to stimulation with Al and LPS, and this up-regulation was greatly exacerbated in the presence of
DPN. However, the up-regulation of SPI-6 gene expression did not result in decreased IL-1β secretion. In conclusion, estrogen receptor agonists did not modulated IL-1β secretion in murine
bone marrow-derived macrophages stimulated with aluminum and LPS, while in the presence
of M-CSF.
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